Healthcare & Life Sciences

Apini Therapeutics

United Kingdom
Sign in to unlock

About

Apini Therapeutics develops a novel small molecule treatment aimed at chronic inflammatory diseases such as Crohn’s disease and Ulcerative Colitis, the two most common forms of inflammatory bowel disease.

Explore Apini Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing